These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25283469)

  • 21. Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain.
    Webster LR; Messina J; Xie F; Nalamachu S
    J Opioid Manag; 2011; 7(4):297-308. PubMed ID: 21957829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric properties of selected tests in patients with lumbar spinal stenosis.
    Cleland JA; Whitman JM; Houser JL; Wainner RS; Childs JD
    Spine J; 2012 Oct; 12(10):921-31. PubMed ID: 22749295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies.
    Merchant S; Provenzano D; Mody S; Ho KF; Etropolski M
    J Opioid Manag; 2013; 9(1):51-61. PubMed ID: 23709304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric properties of the pain assessment in advanced dementia scale compared to self assessment of pain in elderly patients.
    Mosele M; Inelmen EM; Toffanello ED; Girardi A; Coin A; Sergi G; Manzato E
    Dement Geriatr Cogn Disord; 2012; 34(1):38-43. PubMed ID: 22907210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL; Carpenter DM; Minkoff JR
    Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of change in pain intensity: a comparison of the P4 and single-item numeric pain rating scales.
    Spadoni GF; Stratford PW; Solomon PE; Wishart LR
    J Orthop Sports Phys Ther; 2004 Apr; 34(4):187-93. PubMed ID: 15128188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative responsiveness of verbal and numerical rating scales to measure pain intensity in patients with chronic pain.
    Chien CW; Bagraith KS; Khan A; Deen M; Strong J
    J Pain; 2013 Dec; 14(12):1653-62. PubMed ID: 24290445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing the reliability and validity of pain intensity measurement in chronic pain patients.
    Jensen MP; McFarland CA
    Pain; 1993 Nov; 55(2):195-203. PubMed ID: 8309709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
    Rauck RL; Nalamachu S; Wild JE; Walker GS; Robinson CY; Davis CS; Farr SJ
    Pain Med; 2014 Jun; 15(6):975-85. PubMed ID: 24517082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary validation of the Defense and Veterans Pain Rating Scale (DVPRS) in a military population.
    Buckenmaier CC; Galloway KT; Polomano RC; McDuffie M; Kwon N; Gallagher RM
    Pain Med; 2013 Jan; 14(1):110-23. PubMed ID: 23137169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain.
    Nalamachu S; Ruck D; Nalamasu R; Fasbinder S; Bansal R
    J Opioid Manag; 2013; 9(1):43-9. PubMed ID: 23709303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study.
    Barreveld AM; Correll DJ; Liu X; Max B; McGowan JA; Shovel L; Wasan AD; Nedeljkovic SS
    Pain Med; 2013 Jun; 14(6):925-34. PubMed ID: 23786558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using a worst pain intensity measure in children and adolescents.
    Avian A; Messerer B; Meissner W; Sandner-Kiesling A; Kammel J; Labugger M; Weinberg A; Berghold A
    J Adv Nurs; 2017 Aug; 73(8):1873-1883. PubMed ID: 28152231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
    Passik SD; Narayana A; Yang R
    Pain Med; 2014 Aug; 15(8):1365-72. PubMed ID: 24666664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system.
    Kosinski MR; Schein JR; Vallow SM; Ascher S; Harte C; Shikiar R; Frank L; Margolis MK; Vorsanger G
    Curr Med Res Opin; 2005 Jun; 21(6):849-62. PubMed ID: 15969885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical applicability of a daily summary of patients' self-reported postoperative pain-A repeated measure analysis.
    Wikström L; Eriksson K; Fridlund B; Nilsson M; Årestedt K; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4675-4684. PubMed ID: 28334471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.